Axonics® to Participate in September Investor Conferences
- Wall Street closes lower as the Fed pounds rate hike drum
- AMD Shares Down 2% on Disappointing Q3 Preliminary Results
- Musk Failed to Convince Twitter (TWTR) to Lower the Deal Price - Reports
- Fed's Kashkari: 'quite a ways away' from pausing rate hikes
- Citi Says Buy US and UK Equities, Sees 18% Upside in Global Equities to End-2023
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
IRVINE, Calif.--(BUSINESS WIRE)-- Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that senior management is scheduled to present at the following investor conferences:
Event: Wells Fargo Healthcare Conference
Date: Thursday, September 8, 2022
Time: 10:25 a.m. Eastern Time
Event: Morgan Stanley Healthcare Conference
Date: Monday, September 12, 2022
Time: 11:05 a.m. Eastern Time
Interested parties may access a live and archived webcast of each presentation by visiting the Axonics investor relations website.
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
Axonics sacral neuromodulation (SNM) systems provide patients suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company’s best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics’ clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
Source: Axonics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Related EntitiesMorgan Stanley, Wells Fargo
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!